Biologically active parathyroid hormone in familial hypocalciuric hypercalcaemia

Area of Science:

• Endocrinology
• Human Genetics
• Biochemistry

Background:

• Familial hypocalciuric hypercalcaemia (FHH) is a genetic disorder characterized by high calcium levels in the blood and low calcium levels in the urine.
• The exact cause of hypercalcaemia in FHH remains incompletely understood.
• Parathyroid hormone (PTH) plays a crucial role in calcium regulation.

Purpose of the Study:

• To investigate the biological activity of parathyroid hormone (PTH) in a family with familial hypocalciuric hypercalcaemia (FHH).
• To determine if increased biological activity of circulating PTH contributes to the hypercalcaemia observed in FHH patients.

Main Methods:

• Assay of biologically active PTH (bio-PTH) using a cytochemical bioassay.
• Analysis of five family members (three affected) with typical FHH features.
• Measurement of carboxy-terminal immunoreactive PTH levels.

Main Results:

• Biologically active PTH (bio-PTH) levels were within the normal range in all subjects, irrespective of their hypercalcaemic status.
• Carboxy-terminal immunoreactive PTH was undetectable in all analyzed individuals.
• These findings indicate that elevated PTH biological activity does not explain the hypercalcaemia in FHH.

Conclusions:

• The hypercalcaemia in familial hypocalciuric hypercalcaemia (FHH) is not attributable to increased biological activity of circulating parathyroid hormone (PTH).
• Further research is needed to elucidate the underlying mechanisms of FHH pathogenesis.
• The study highlights the importance of differentiating FHH from other hypercalcaemic conditions.